Sanofi (SNY)
NASDAQ: SNY · Real-Time Price · USD
40.07
-0.16 (-0.40%)
At close: Oct 9, 2026, 4:00 PM EDT
40.24
+0.17 (0.42%)
After-hours: Oct 9, 2026, 7:52 PM EDT

Sanofi Financials Overview

Millions EUR. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Revenue
12,30011,24412,20513,17010,73510,606-14,157-11,118-12,69810,58810,86311,45613,13810,74210,05310,41510,829
Revenue Growth
14.58%6.02%--6.97%--4.61%-11.49%-2.35%--3.35%-1.43%8.06%9.99%21.32%18.76%13.13%6.97%9.62%
Gross Profit
9,4118,1888,5759,7587,7437,717-10,072-7,679-8,8577,3257,7847,7259,3077,4957,1736,9437,591
Operating Income
2,5872,2491,7403,7841,7122,424-4,079-2,032-3,4771,5462,8211,6614,6521,8412,5731,2403,203
Net Income
3431,614-8012,8023,9401,872-2,815-1,133-2,5251,4351,9953,1112,0761,1752,0091,1302,317
Earnings Per Share
0.281.34-0.662.303.231.52-2.25-0.91-2.011.141.602.481.660.941.610.901.85
EPS Growth
-91.20%-11.66%-2.39%-67.22%-11.50%--43.19%-21.66%21.70%-0.70%175.50%-10.33%-0.91%28.30%6.52%18.81%

Revenue by Segment

Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Dupixent
5,1544,1704,2464,1563,8323,4803,4583,4763,3032,8352,9902,8472,5622,3162,4022,3141,9631,6141,5491,410
Pharma
10,4489,2169,2649,0778,7818,5688,3888,3558,2977,762----------
Total Vaccine
1,1491,2932,0393,3571,2131,3272,1763,8021,1421,1771,9863,0981,2231,1671,7163,3151,1781,0201,9642,422
Revenue (Total)
12,30011,24412,20513,17010,73510,60611,42012,97711,3809,72612,20111,54010,6829,47011,45613,13810,74210,05310,41510,829

Cash & Debt

Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Cash & Investments
6,3505,5447,6748,90615,3597,9917,5566,7956,7958,7108,8227,9937,99312,73612,7366,8996,89910,10910,1099,722
Total Debt
23,57620,02120,41021,75522,28521,04717,91323,75123,75118,42318,42321,02721,02721,21221,21221,23721,23722,41522,41521,649
Net Cash (Debt)
-17,226-14,477-12,736-12,849-6,926-13,056-10,357-16,956-16,956-9,713-9,601-13,034-13,034-8,476-8,476-14,338-14,338-12,306-12,306-11,927
Net Cash Growth
--------------------
Net Cash Per Share
-14.40-12.02-10.50-10.55-5.69-10.58--13.53--7.78--10.40-10.42-6.78-6.76-11.44-11.46-9.85-9.81-9.51

Cash Flow & CapEx

Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Operating Cash Flow
2,9601,6833,4453,7501,4622,093--------------
Capital Expenditures
-882--1,762845-845---------------
Free Cash Flow
2,0781,6831,6834,5956172,093--------------
Free Cash Flow Growth
236.79%-19.59%------------------

Margins

Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Gross Margin
76.51%72.82%70.26%74.09%72.13%72.76%-71.14%-69.07%-69.75%69.18%71.66%67.43%70.84%69.77%71.35%66.66%70.10%
Operating Margin
21.03%20.00%14.26%28.73%15.95%22.86%-28.81%-18.28%-27.38%14.60%25.97%14.50%35.41%17.14%25.59%11.91%29.58%
Pretax Margin
6.73%17.91%-9.46%26.64%13.67%20.74%-25.29%-11.78%-24.42%16.23%22.72%35.60%20.40%12.87%23.37%13.51%27.26%
Profit Margin
2.79%14.35%-6.56%21.28%36.70%17.65%-19.88%-10.19%-19.89%13.55%18.37%27.16%15.80%10.94%19.98%10.85%21.40%
FCF Margin
16.89%14.97%13.79%34.89%5.75%19.73%--------------

Dividends

Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Dividend Per Share
--4.120-----------3.560---3.330
Dividend Per Share Growth
--------------6.91%----
Dividend Yield
--10.38%-----------8.92%---8.82%

Valuation

Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
PE Ratio
22.8013.22-11.1011.6126.62-32.67-22.30-14.0314.2514.9813.4615.3918.1717.3617.9016.98
P/FCF Ratio
8.9911.6511.2013.0836.9659.61--------------
PS Ratio
1.852.112.152.772.825.04-5.10-3.30-2.792.672.712.482.222.872.862.842.71